[HTML][HTML] Using iPS cells toward the understanding of Parkinson's disease

R Torrent, F De Angelis Rigotti, P Dell'Era… - Journal of clinical …, 2015 - mdpi.com
Cellular reprogramming of somatic cells to human pluripotent stem cells (iPSC) represents
an efficient tool for in vitro modeling of human brain diseases and provides an innovative …

What we can learn from iPSC-derived cellular models of Parkinson's disease

MC Caiazza, C Lang, R Wade-Martins - Progress in Brain Research, 2020 - Elsevier
Parkinson's disease (PD) is an age-related neurodegenerative disorder with no known cure.
In order to better understand the pathological mechanisms which lead to neuronal cell death …

[HTML][HTML] Dissecting the non-neuronal cell contribution to Parkinson's disease pathogenesis using induced pluripotent stem cells

M Pons-Espinal, L Blasco-Agell, A Consiglio - Cellular and Molecular Life …, 2021 - Springer
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with
characteristic movement impairments that are caused by the progressive loss of dopamine …

Stem Cells as In Vitro Model of Parkinson′s Disease

PL Martínez-Morales, I Liste - Stem cells international, 2012 - Wiley Online Library
Progress in understanding neurodegenerative cell biology in Parkinson′ s disease (PD)
has been hampered by a lack of predictive and relevant cellular models. In addition, the lack …

[HTML][HTML] Creation of a library of induced pluripotent stem cells from Parkinsonian patients

S Holmqvist, Š Lehtonen, M Chumarina… - npj Parkinson's …, 2016 - nature.com
Induced pluripotent stem cells (iPSCs) are becoming an important source of pre-clinical
models for research focusing on neurodegeneration. They offer the possibility for better …

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease

LW Chen, F Kuang, LC Wei, YX Ding… - CNS & Neurological …, 2011 - ingentaconnect.com
Parkinson's disease (PD), a common degenerative disease in humans, is known to result
from loss of dopamine neurons in the substantia nigra and is characterized by severe motor …

[HTML][HTML] Using induced pluripotent stem cells for modeling Parkinson's disease

M Ke, CM Chong, H Su - World journal of stem cells, 2019 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is an age-related neurodegenerative disease caused by the
progressive loss of dopaminergic (DA) neurons in the substantia nigra. As DA neurons …

[HTML][HTML] One step into the future: new iPSC tools to advance research in Parkinson's disease and neurological disorders

NV Mohamed, F Larroquette, LK Beitel… - Journal of …, 2019 - content.iospress.com
Studying Parkinson's disease (PD) in the laboratory presents many challenges, the main
one being the limited availability of human cells and tissue from affected individuals. As PD …

Solving the puzzle of Parkinson's disease using induced pluripotent stem cells

P Zhao, Z Luo, W Tian, J Yang… - Experimental …, 2014 - journals.sagepub.com
The prevalence and incidence of Parkinson's disease (PD) is increasing due to a prolonged
life expectancy. This highlights the need for a better mechanistic understanding and new …

Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease

A Sánchez‐Danés, Y Richaud‐Patin… - EMBO molecular …, 2012 - embopress.org
Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human
disease in relevant cell types, but it is unclear whether they could successfully model age …